Clinical Trial Update: ORKA-001 Versus Placebo in Patients With Moderate-to-Severe Plaque Psoriasis [Phase 2]

View source ↗

Summary

This is a Phase 2 trial update for ORKA-001 versus placebo in moderate-to-severe plaque psoriasis; the study is currently ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• ORKA-001

Snippet

Sponsor: Oruka Therapeutics, Inc. | Conditions: Plaque Psoriasis | Phase 2 | Status: ACTIVE_NOT_RECRUITING